Elevance lowers profit outlook, warns things will get worse for health insurers

Elevance became the fourth major health insurer to lower its full-year profit outlook, cutting it by 13%, citing significantly higher-than-projected medical costs driven by increased care utilization across its Affordable Care Act and Medicaid businesses, leading to an 11% drop in its shares. Executives described this as a broader "market-wide morbidity shift" affecting the entire industry, with costs expected to persist into 2026, partly due to the impending expiration of ACA enhanced premium tax credits. This trend, also seen at UnitedHealth and Centene, is causing analysts to view fiscal year 2025 as a challenging period for the sector.

Analysis

Elevance Health has become the fourth major U.S. health insurer to reduce its profit forecast, signaling a systemic issue across the managed care sector. The company lowered its full-year profit outlook by 13%, citing a significant, industry-wide increase in medical costs that precipitated an 11% drop in its share price. This revision follows similar negative guidance from UnitedHealth, Centene, and Molina. Management attributed the higher costs to a "market-wide morbidity shift," with pressures concentrated in its Affordable Care Act (ACA) and Medicaid businesses, while its Medicare Advantage segment performed as expected—a notable distinction from UnitedHealth's earlier warnings. The drivers for cost inflation have shifted; two-thirds of the increase is now due to higher care utilization and aggressive provider coding, a reversal from 2024 when patient acuity was the primary factor. Despite a 14% year-over-year revenue increase to $49.4 billion in Q2, profit fell 24% to $1.7 billion, underscoring severe margin compression. Looking ahead, these cost trends are expected to persist, with a potential surge in care utilization near the end of 2025 ahead of the scheduled expiration of enhanced ACA premium tax credits, a development that analysts at Mizuho suggest is causing the market to write off fiscal 2025 as a "throwaway year."

Key Decisions for Investors

• Given the industry-wide cost pressures and negative guidance from multiple major insurers, investors should anticipate continued volatility and margin compression in the managed care sector through 2025.
• Portfolio managers should differentiate between insurers based on their exposure; Elevance's guidance highlights acute stress in ACA and Medicaid segments, suggesting relative stability for players less dependent on these markets.
• Monitor legislative discussions around the Affordable Care Act's enhanced premium tax credits, as their expiration at year-end 2025 is a major catalyst that could accelerate medical loss ratios before a subsequent drop in enrollment.
• While the 11% sell-off in Elevance may attract value-oriented investors, initiating or adding to a position requires a long-term view that looks past the widely anticipated difficulties of 2025 toward a potential recovery in 2026.